Literature DB >> 24070219

Surgical management of ichtyosis-related ectropion. Description of four cases and a literature review.

Mateusz G Zachara1, Piotr H Drozdowski, Ireneusz T Łątkowski.   

Abstract

Ichtyosis is an heterogeneous group of diseases characterized by formation of hyperkeratotic, squamous, tile-like scales virtually on the whole body. Depending on the severity and localization of the symptoms, the disease may lead to serious complications including ectropion of the eyelids, which may further lead to ocular disorders, including blindness. The aim of the work was to outline major characteristics of the entity and to focus on surgical methods of ichtyosis-related eyelid ectropion management. Four cases of ichtyosis-related eyelid ectropion, which occurred in patients presenting severe symptoms of the disease treated surgically in the clinic between 2003-2011, were described. In all patients the eyelid contractures were successfully released and relief of conjunctival inflammation was obtained. No postoperative complications occurred. In two patients, a secondary operation was necessary due to skin graft contracture and ectropion recurrence. In some cases, ichtyosis may lead to serious ocular complications. Surgical management of eyelid ectropion is challenging due to the shortage of available lesion-free skin for grafting and due to possible skin graft contracture leading to recurrence.

Entities:  

Keywords:  Ichtyosis; ectropion; skin graft

Mesh:

Year:  2013        PMID: 24070219     DOI: 10.3109/2000656X.2013.842923

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  2 in total

Review 1.  Management of Harlequin Ichthyosis: A Brief Review of the Recent Literature.

Authors:  Maria Tsivilika; Dimitrios Kavvadas; Sofia Karachrysafi; Antonia Sioga; Theodora Papamitsou
Journal:  Children (Basel)       Date:  2022-06-15

2.  Combined medical and surgical management for cicatricial ectropion in lamellar ichthyosis: A report of three cases.

Authors:  Nirmala Subramanian; Pratheeba Devi Nivean; Md Shahid Alam
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.